Proton beam therapy and localised prostate cancer: current status and controversies
Open/View files
Date
2013
Author(s)
Efstathiou, J A
Gray, P J
Zietman, A L
Publisher
Nature Publishing Group
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Efstathiou, J A, P J Gray, and A L Zietman. 2013. “Proton beam therapy and localised prostate cancer: current status and controversies.” British Journal of Cancer 108 (6): 1225-1230. doi:10.1038/bjc.2013.100. http://dx.doi.org/10.1038/bjc.2013.100.
Abstract
Proton therapy is a promising, but costly, treatment for prostate cancer. Theoretical physical advantages exist; yet to date, it has been shown only to be comparably safe and effective when compared with the alternatives and not necessarily superior. If clinically meaningful benefits do exist for patients, more rigorous study will be needed to detect them and society will require this to justify the investment of time and money. New technical advances in proton beam delivery coupled with shortened overall treatment times and declining device costs have the potential to make this a more cost-effective therapy in the years ahead.
Other Available Sources
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection